Bernard Taverne, Alice Desclaux, Papa Salif Sow

Publications issues de la cohorte ANRS 1215, 1999-2012Publications dans des revuesde rang Aird-00718213, version 1 - 16 Jul 20121. Touré-Kane C., Montavon C., Awa Faye M., Mandoumbé GueyeP., Salif Sow P., Ndoye I., Gaye Diallo A., Delaporte E., Peeters M.,Mboup S. Identification of all HIV-1 groupe M subtypes in Senegal,a country with low and stable seroprevalence. AIDS Res and HumRetroviruses 2000 16 – 6: 603-6092. Vergne Laurence, Peeters Martine, Mpoudi-Ngole Eitel,Bourgeois Anke, Liegeois Florian, Touré-Kane Coumba, MboupSouleymane, Mulanga-Kabeya Claire, Saman Eric, JourdanJacques, Delaporte Eric. Genetic diversity of protease and reversetranscriptase sequences of non-B HIV-1 strains: evidence for manyminor drug resistant mutations in tretment-naive individuals. Journalof Clinical Microbiology. 2000, Vol 38, N°11, pp 3919-3923. Coumba Toure Kane, Céline Montavon, Mama Awa Toure,Mame Awa Faye, Aissatou Gueye Ndiaye, Aissatou Gaye Diallo,Ibra Ndoye, Eric Saman, Florian Liegeois, Eric Delaporte, SouleymaneMboup, Martine Peeters. Full-length genome sequencing ofHIV – 1 grjoup O viruses isolated from a heterosexual transmissioncluster in Senegal. AIDS Research and Human Retroviruses. 2001Aug ; 17(12):1211-6.4. Gao F, Vidal N, Li Y, Trask SA, Chen Y, Kostrikis LG, Ho DD, KimJ, Oh MD, Choe K, Salminien M, Robertson DL, Shaw GM, HahnBH, Peeters M. Evidence of two distinct subtypes within the HIV-1subtype A radiation. AIDS Res Hum Retrovir, 2001, 17 (8): 675-88.5. Taverne B., Pour une délivrance gratuite des traitements antirétrovirauxen Afrique. Bull. Soc. Pathol. Exo., T. 96, n° 3, pp. 241-244.2003.6. Laurent C, Diakhaté N, Ngom Gueye NF, Touré MA, Sow PS,Faye MA, Gueye M, Lanièce I, Touré Kane C, Liégeois F, Vergne L,Mboup S, Badiane S, Ndoye I, Delaporte E. The Senegalesegovernment's highly active antiretroviral therapy initiative : an18-month follow-up study. AIDS 2002, Vol 16, pp 1363-13707. Montavon C, Touré Kane C, Nkengasong J. N, Vergne L,Hertogs K, Mboup S, Delaporte E and Peeters M. CRF06-cpx : anew circulating recombinant form of HIV-1 in west Africa involvingsubterfuges A, G, K, and J. JAIDS 2002 ; 29 : 522-5308. Desclaux A., Ciss M., Taverne B., Sow P.S., Egrot M., FayeM.A., Lanièce I., Sylla O., Delaporte E., Ndoye I., Access to antiretroviraldrugs and AIDS management in Senegal. AIDS, 2003 , Vol.17 (suppl3) S95-S101.9. Desclaux A., Les antirétroviraux en Afrique : de la culture dansune économie mondialisée. Anthropologie et sociétés, 27 (2) :41-58. 2003.10. Desclaux A., Levy J., Cultures et médicaments. Ancien objet ounouveau courant en anthropologie médicale ? Introduction dunuméro thématique d'Anthropologie et sociétés sur "Culture etmédicaments", 27 (2) : 5-21. 2003.11. Laniéce I, Ciss M., Desclaux A., Diop K., Mbodj F., Ndiaye B.,Sylla O., Delaporte E., Ndoye I., Adherence to HAART and itsprincipal determinants in a cohort of Senegalese HIV-infectedadults, AIDS, 17 (suppl3) S103-108. 2003.12. Vergne L, Toure Kane C, Laurent C, Diakhate N, Ngom GueyeNF, Gueye PM? Sow PS, Faye MA, Liegeois F, Ndir A, Laniece I,Peeters M, Ndoye I, Mboup S, Delaporte E. Low rate of genotypicHIV-1 drug-resistant strains in the Senegalese government initiativeof access to antiretroviral therapy. AIDS, 2003, 17 (suppl 3):S31-S38.13. Furber A., Hodgson I., Desclaux A., Mukasa D., Barriers forbetter care for people with AIDS in developing countries. BritishMedical Journal, 2004, 329 : 1281-1283.14. Dabis F, Balestre E, Braitstein P, Miotti P, Brinkhof MWG,Schneider M, Schechter M, Laurent C, Boulle A, Kabugo C, CapkunG, Seyler C, McIntyre J, Sprinz E, Bansgberg D, Van der Borght S,Egger M for The Antiretroviral Therapy in Lower Income Countries(ART-LINC) Study Group. Antiretroviral therapy in lower incomecountries (ART-LINC): international collaboration of treatmentcohorts. Int J Epidemiol, 2005, 34(5): 979-86.15. Laurent C, Ngom Gueye NF, Ndour CT, Gueye PM, Diouf M,Diakhate N, Toure Kane NC, Laniece I, Ndir A, Vergne L, Ndoye I,Mboup S, Sow PS, Delaporte E; ANRS 1215/1290 Study Group.Long-term benefits of highly active antiretroviral therapy in SenegaleseHIV-1-infected adults. J Acquir Immune Defic Syndr. 2005 Jan1;38(1):14-7.16. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, MiottiP, Wood R, Laurent C, Sprinz E, Seyler C, Bangsberg DR, BalestreE, Sterne JA, May M, Egger M, for The Antiretroviral Therapy inLower Income Countries (ART-LINC) Collaboration and ART CohortCollaboration (ART-CC) Groups. Mortality of HIV-1-infected patientsin the first year of antiretroviral therapy: comparison between low-incomeand high-income countries. Lancet 2006, 367(9513): 817-24.17. Etard JF, Ndiaye I, Thierry-Mieg M, Ngom Guèye NF,Mandoumbé Guèye P, Lanièce I, Dieng AB, Diouf A, Laurent C,Mboup S, Sow PS and Delaporte E, for the ANRS 1290 study group.Mortality and causes of death in adults receiving HAART in Senegal:a 7-year cohort study AIDS 2006, 20(8): 1181-118918. Etard JF, Lanièce I, Koita Fall MB, Cilote V, Blazejewski L, DiopK, Desclaux A, Ecochard R, Ndoye I, Delaporte E and ANRS1215/90 study group. A 84-month follow-up of adherence to HAARTin a cohort of adults Senegalese patients. Trop Med Int Hlth 2007,12(10):1191-1198.19. De Beaudrap P, Etard J, Ecochard R, Diouf A, Dieng A, Cilote V,et al. Change over time of mortality predictors after HAART initiationin a Senegalese cohort. Eur J Epidemiol. 2008;23(3):227-234.20. Desclaux A., O medicamento, um objeto de futuro na anthropologiade saùde. Revista Mediaçoes, Londrina, 2008, II (2), 113-13021. De Beaudrap P., Jean-François Etard, Fatou Ngom Guèye,Mandoumbe Guèye, Roland Landman, Pierre-Marie Girard , PapaSalif Sow, Ibrahima Ndoye, Eric Delaporte. Long-term efficacy andtolerance of efavirenz- and nevirapine-containing regimens in adultHIV-1 Senegalese patients. AIDS Res and Hum Retroviruses 2008Jun;24(6):753-60.22. Etard Jean-Francois, De Beaudrap Pierre, Koivugui Akoi,Ngom-Gueye Ndeye Fatou, Ndiaye Ibrahima, Ecochard Rene, SowPapa Salif, Delaporte Eric. Short and Long-Term Incidence of Tuberculosisand CD4-Cell Count Dynamic on HAART in Senegal. TheOpen AIDS Journal. (2009);3:63-70.23. Mercier S, Gueye NF, Cournil A, Fontbonne A, Copin N, NdiayeI, Dupuy AM, Cames C, Sow PS, Ndoye I, Delaporte E, SimondonKB. Lipodystrophy and metabolic disorders in HIV-1-infected adultson 4- to 9-year antiretroviral therapy in Senegal: a case-controlstudy. J Acquir Immune Defic Syndr. (2009);51(2):224-230.24. De Beaudrap P, Etard JF, Diouf A, Ndiaye I, Gueye NF, GueyePM, Sow PS, Mboup S, Ndoye I, Ecochard R, Eric D. ModelingCD4+ cell count increase over a six-year period in hiv-1-infectedpatients on highly active antiretroviral therapy in Senegal. Am J TropMed Hyg. (2009);80(6):1047-1053.25. Tournoud M, Etard JF, Ecochard R, DeGruttola V. Adherence toantiretroviral therapy, virological response, and time to resistance inthe Dakar cohort. Stat Med. (2010);29(1):14-3226. Bastard M., Koita Fall M.B., Lanièce I., Taverne B., Desclaux A.,Ecochard R., Sow P.S., Delaporte E., Etard J.F., Revisitinglong-term adherence to ART in Senegal using latent class analysis.Journal of AIDS27. Cournil A, Eymard-Duvernay S, Diouf A, Moquet C, Coutherut J,et al. (2012) Reduced Quantitative Ultrasound Bone Mineral Densityin HIV-Infected Patients on Antiretroviral Therapy in Senegal. PLoSONE 7(2): e31726. doi:10.1371/journal.pone.0031726